Data de publicação: 13/05/2021 - 11:57
Fiocruz is taking part of the survey COVID-19: our care, our actions, their effects, with the goal of getting to know better the treatments and preventive actions that people from all over the world have been experiencing in the context of the disease. Spearheaded by the Antenna Foundation, a Swiss NGO that offers technological and medical solutions to populations in need, the survey boasts the collaboration of universities and research...
Notícias
Data de publicação: 11/05/2021 - 08:58
Although studies suggest that children and adolescents attending summer camps and social events may carry COVID-19 into their homes, work by researchers at the Oswaldo Cruz Foundation (Fiocruz), the University of California (UCLA), and the London School of Hygiene and Tropical Medicine (LSHTM) indicates that they more often become infected by adults than act as transmitters.
A preview of the article SARS-CoV-2 Infection Dynamics in Children...
Notícias
Data de publicação: 06/05/2021 - 08:01
The pandemic brought challenges, but also opportunities, according to lecturers on the 6th annual Multi-stakeholder Forum on Science, Technology, and Innovation for the Sustainable Development Goals (SDG), also known as the STI Forum. In Lessons from the COVID-19 Pandemic, the forum’s first session, on Tuesday May 4th, specialists on the fields of sciences, technology and economics analyzed the scenario and looked for ways to recover and...
Notícias
Data de publicação: 06/05/2021 - 07:59
The pandemic brought challenges, but also opportunities, according to lecturers on the 6th annual Multi-stakeholder Forum on Science, Technology, and Innovation for the Sustainable Development Goals (SDG), also known as the STI Forum. In Lessons from the COVID-19 Pandemic, the forum’s first session, on Tuesday May 4th, specialists on the fields of sciences, technology and economics analyzed the scenario and looked for ways to recover and...
Notícias
Data de publicação: 29/04/2021 - 18:08
Two drugs used against hepatitis C have been proven effective in inhibiting Sars-CoV-2 replication in cells in laboratory studies. The trial is now entering its phase 2: tests in patients. The results of the first phase of the trial, led by researchers of the Oswaldo Cruz Foundation (Fiocruz), were published on April 21 in a paper for the Journal of Antimicrobial Chemotherapy, by Oxford Academic. The results of phase 2 will likely be known in...
Notícias
Data de publicação: 28/04/2021 - 12:55
Published on April 24, the Bulletin of the Fiocruz COVID-19 Observatory, referring to Epidemiological Weeks (EW) 14 and 15, between 4 and 17 April, presents a general overview of the Covid-19 situation in the country and its implications. The new edition shows that the pandemic is hitting younger people. The number of cases and deaths by Covid-19 per age group shows that the differential increase per age group is steady. According to the...
Notícias
Data de publicação: 20/04/2021 - 16:01
A study by researchers of the Oxford University shows that the risk of cerebral venous thrombosis (CVT) in people with COVID-19 is considerably higher than in those who have been vaccinated with mRNA (messenger RNA) vaccines, such as those by Pfizer and Moderna. In addition to mRNA vaccines, the analysis also included the Oxford/AstraZeneca immunizer, produced in Brazil by the Oswaldo Cruz Foundation (Fiocruz).
The survey Cerebral venous...
Notícias
Data de publicação: 19/04/2021 - 15:55
A “pandemic of inequalities”, which denies people access to water to wash their hands, is one of the factors that have worsened the dissemination of Sars-CoV-2 in Latin America and in the Caribbean. This is the assessment of the UN High Commissioner for Human Rights and former president of Chile, Michelle Bachelet. A physician herself, last Thursday (April 15) she opened the Advanced Seminaries on Global Health and Health Diplomacy...
Notícias
Data de publicação: 14/04/2021 - 18:22
Many viruses can hamper coagulation, including those that cause dengue fever and yellow fever. In more severe cases, they may lead to bleeding. This is why these diseases are considered hemorrhagic viral fevers. In a paper recently published in the science magazine “Memórias do Instituto Oswaldo Cruz”, a group of ten researchers argues that the new coronavirus (SARS-CoV-2) should be the first agent recognized as acting in the...
Notícias
Data de publicação: 12/04/2021 - 12:42
A methodology that aims to make the monitoring of the new coronavirus variants simpler and faster, besides being cheaper, has just been developed at Fiocruz Pernambuco. It is based on a technique that is already widely used and available in Brazil and in the world, the Sanger sequencing - also called sequencing by capillary electrophoresis. The article with this finding has just been made available online as a preprint on the MedRxiv platform....
Notícias
Data de publicação: 09/04/2021 - 09:08
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates.
(Photo:Isabela Carrari -...
Notícias
Data de publicação: 06/04/2021 - 09:24
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to...
Notícias
Data de publicação: 01/04/2021 - 10:02
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups.
The first group includes urgent measures that involve the containment of the...
Notícias
Data de publicação: 26/03/2021 - 14:14
Autoras: Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham.
Publicação original em inglês.
Confira mais informações no Observatório Covid-19.
Acesse o especial da Fiocruz sobre a Covid-19.
Documento/Arquivo
Data de publicação: 26/03/2021 - 11:50
Science formulated with collaboration and transparency. On March 17th, the Oswaldo Cruz Foundation (Fiocruz) presented the advances in the implantation of the Institutional Data Repository for Research - Arca Dados, an important element to implement the Policy for Management, Sharing and Opening of Data for Research. The document (approved in September 2020 by the Deliberative Council of Fiocruz and whose Ordinance came into term in December) is...
Notícias
Data de publicação: 18/03/2021 - 13:30
The United Kingdom ambassador in Brazil, Peter Wilson, visited the Oswaldo Cruz Foundation (Fiocruz) on March 5 for a meeting with the president of the institution, Nísia Trindade Lima, and to visit the Immunobiological Technology Institute (Bio-Manguinhos) plant that is producing the Covid-19 Fiocruz vaccine.
Photo: Pedro Paulo Gonçalves
“I greatly admire the work you have you been doing, and we are here to know...
Notícias
Data de publicação: 17/03/2021 - 09:46
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil.
The Bulletin shows that, at the moment, of the...
Notícias
Data de publicação: 15/03/2021 - 11:54
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the...
Notícias
Data de publicação: 12/03/2021 - 11:49
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese)....
Notícias
Data de publicação: 10/03/2021 - 18:21
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and...
Notícias
Data de publicação: 10/03/2021 - 12:53
Many affluent countries, with the necessary technological capabilities and expertise, entered into the production of Covid-19 vaccines or sought the biopharmaceutical companies to block them for themselves through anticipated buying. It is estimated that as early December 2020, 3.8 billion vaccine doses had been guaranteed to these countries by several producers. If one compares that figure with the 3.2 billion doses, that include the 700...
Notícias
Data de publicação: 08/03/2021 - 10:01
A pioneering study used the genomic sequencing of samples of Mycobacterium tuberculosis to assess the resistance of indigenous peoples to anti-tuberculosis drugs. Published on Scientific Reports, a magazine of the Nature group, the research also revealed a high frequency of polymorphisms associated with resistance to the main drugs used in the treatment. The article, titled Identification of a predominant genotype of...
Notícias
Data de publicação: 25/02/2021 - 13:22
The Fiocruz Genomic Network is participating in a project by the Ministry of Health that will sequence new coronavirus samples throughout the national territory. Currently, only three central laboratories (Lacens) in the states are capable of this task. The Network brings together researchers from various institutes of the Foundation to study genetics and genomes of viruses, bacteria, fungi, parasites, and humans, in addition to receiving...
Notícias
Data de publicação: 25/02/2021 - 11:42
On February 5, the Ministry of Health (MoH) and Fiocruz launched a public notice for the construction of the Industrial Complex of Biotechnology in Health (Cibs, in the Portuguese acronym). The document opens a bidding process for hiring investors interested in participating in the construction of a new complex of the Immunobiological Technology Institute of the Oswaldo Cruz Foundation (Bio-Manguinhos/Fiocruz), in Santa Cruz, in Rio de Janeiro....
Notícias
Data de publicação: 05/02/2021 - 10:57
A project of Fiocruz Pernambuco was selected in a public call released by the Federal Government in a partnership with other countries that are part of BRICS - formed by Brazil, Russia, India, China and South Africa. The public notice’s resources had R$6.2 million provided by the Ministry of Science, Technology and Innovation and R$1 million provided byt the Ministry of Health to fund researches directed to facing the Covid-19 pandemic...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
